Navigation Links
Biovista Announces the Appointment of Clifford H. Farrah to its Advisory Board
Date:7/13/2010

CHARLOTTESVILLE, Virginia, July 13, 2010 /PRNewswire/ -- Biovista announced today the appointment of Mr. Clifford H. Farrah, President and Chairman of The Beacon Group, to its Advisory Board.

"We are very excited to have Cliff join our Advisory Board," said Aris Persidis, President of Biovista. "Cliff brings a wealth of direct commercial development experience in the healthcare and biotech market that will be invaluable to us as we grow Biovista," he added.

"Biovista is a new generation biotechnology company with unique technology and capabilities," said Mr. Farrah. "It's rare that you get the opportunity to help a company lead in the new order of drug discovery and development. Biovista is offering a disruptive, rigorous and efficient approach to a costly process, and I am excited to participate in its future."

About the Beacon Group (http://www.tbg-online.com):

The Beacon Group is a strategy consulting firm providing guidance to organizations on their most critical business issues. With a clear focus on achieving top-line growth through both organic and inorganic means, Beacon's output is designed to have a direct impact on client profitability. Healthcare practice base includes Fortune 100 biotech, pharmaceutical, medical device and diagnostics companies.

About Biovista (http://www.biovista.com):

Biovista is a privately held biotechnology company that finds novel uses for existing drugs, and profiles their side effects using their mechanism of action. Biovista is developing its own pipeline of drugs in multiple sclerosis, epilepsy, specific cancers and auto-immune diseases. Also, Biovista is collaborating with the FDA on prediction of adverse events, and with biopharmaceutical companies on indication expansion and de-risking of their portfolios.

    For further information please contact:

    Dr. Aris Persidis
    Biovista, Inc.
    arisp@biovista.com
    +1-434-242-6514



'/>"/>
SOURCE Biovista
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biovista Inc. and FDA to Collaborate on a Medication Safety Initiative
2. Biovista Inc. Named Top Innovator in Life Sciences
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... WARSAW, Ind. , Feb. 24, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Conference at the Boston Marriott Copley Place on Tuesday, ... A live webcast of the presentation can ... be archived for replay following the conference via Zimmer ...
(Date:2/24/2017)... Pa. , Feb. 24, 2017 Physician ... of Drug and Alcohol Programs Jennifer Smith ... in providing training for and using naloxone, a life-saving ... Mark McCullough , a recovery specialist and overdose survivor ... by EMS providers. "A significant part of ...
(Date:2/24/2017)... , Feb. 23, 2017 The ... of the PhenoTest BC Kit, performed on the ... identify organisms that cause bloodstream infections and provide ... to respond to (antibiotic sensitivity). The test also ... provide this important information, which can guide antibiotic ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals (iaedp) announces the ... body image mannequin art competition. Selected from 15 submissions from around the nation, the ... the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The ... for excellence in radiology marketing programs at the annual Building Better Radiology Marketing ... Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given out in ...
(Date:2/24/2017)... Emeryville, CA (PRWEB) , ... February 24, 2017 ... ... Esparza for qualifying into the Senior International Elite division on February 12th. ... All Around divisions at the elite qualifier competition held in Las Vegas, Nevada. ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... announced an official 2017 partnership with The Jensie Gran Fondo of Marin. For ... and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... The 89th ... the winner of the 2016 National Education Policy Center Bunkum Award. We invite you ... in 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), ...
Breaking Medicine News(10 mins):